Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
- 3 May 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 40  (23) , 6112-6128
- https://doi.org/10.1039/c1dt10379b
Abstract
Metallic radionuclides are the mainstay of both diagnostic and therapeutic radiopharmaceuticals. Therapeutic nuclear medicine is less advanced but has tremendous potential if the radionuclide is accurately targeted. Great interest exists in the field of inorganic chemistry for developing target specific radiopharmaceuticals based on radiometals for non-invasive disease detection and cancer radiotherapy. This perspective will focus on the nuclear properties of a few important radiometals and their recent applications to developing radiopharmaceuticals for imaging and therapy. Other topics for discussion will include imaging techniques, radiotherapy, analytical techniques, and radiation safety. The ultimate goal of this perspective is to introduce inorganic chemists to the field of nuclear medicine and radiopharmaceutical development, where many applications of fundamental inorganic chemistry can be found.This publication has 142 references indexed in Scilit:
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- Effect of DOTA Position on Melanoma Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone PeptideBioconjugate Chemistry, 2009
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Standardized methods for the production of high specific-activity zirconium-89Published by Elsevier ,2009
- Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and ChallengesBioconjugate Chemistry, 2009
- A new bifunctional chelator for copper radiopharmaceuticals: a cage amine ligand with a carboxylate functional group for conjugation to peptidesChemical Communications, 2009
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)Journal of Medicinal Chemistry, 2008
- Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesPublished by Elsevier ,2008
- Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64 Cu-SarAr immunoconjugatesProceedings of the National Academy of Sciences, 2007
- Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out viewNuclear Medicine and Biology, 2007